Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

AstraZeneca’s Tagrisso shows promise as lung cancer maintenance therapy

Up to 85% of lung cancer patients are diagnosed with non-small cell lung cancer

- PMLiVE

Cambridge study reveals potential biomarker and target for long COVID treatments

The pro-inflammatory molecule, IFN-Y, persisted until symptoms improved in patients

- PMLiVE

Besins Healthcare appoints Irina Spirieva as general manager for UK and Ireland

Spirieva joins the company from Organon, a Merck & Co company

- PMLiVE

Rare, But Out There: The art of reaching rare disease patients through understanding human experience

Director Helena Wright talks about the importance of understanding the beliefs, emotional drivers and cultural factors that underpin the experience of living with a rare disease, as we mark Rare...

Havas Life London

- PMLiVE

Alexion launches ‘colourUp4RARE challenge’ to mark Rare Disease Day 2024

The campaign is aimed at raising awareness of how to improve quality of life for patients

- PMLiVE

AbbVie and Tentarix partner to develop oncology and immunology biologics

The collaboration will use Tentarix's proprietary platform to develop biologics against two targets

- PMLiVE

ABPI sets out UK life sciences industry’s priorities for government’s budget

The ABPI highlights four key areas where the budget could boost UK life sciences

- PMLiVE

New drug interaction model could improve drug safety and effectiveness

The model found that the antibiotic doxycycline could interact with a common blood thinner, warfarin

- PMLiVE

Key product launch challenges: creating a successful product launch

Launching a treatment is a complex process that involves maximizing impact for all stakeholders, from providers to patients. It requires the strategic alignment of each pivotal moment, from regulatory approvals...

- PMLiVE

Pfizer’s Litfulo recommended by NICE as first treatment for severe alopecia areata

Up to 14,000 patients living with the autoimmune disease could benefit from NICE’s decision

- PMLiVE

AbbVie’s Produodopa rolled out by NHS England for advanced Parkinson’s patients

The roll out follows NICE’s recommendation of the treatment in October 2023

- PMLiVE

Johnson & Johnson’s Tecvayli receives FDA approval for reduced dosing in multiple myeloma patients

More than 35,000 cases of the blood cancer are expected to be diagnosed in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links